Latest / Executive Careers with Fexingo: VP, C-Suite, and Senior Leadership Career Strategy / How Senior Leaders Vet Board Seats Before Accepting
Transcript
- Lucas: Luna, I've been thinking about a moment in Anne Mulcahy's career that doesn't get enough attention — her decision to join the Target board in 2005. Luna: The former Xerox CEO? I remember she was on the board during Target's 2013 data breach. That must have been a stress test. Lucas: Exactly. But what's interesting is what happened before that. Mulcahy has said publicly that when she was approached about the Target seat, she spent months doing what she called 'deep diligence' — not just on the company's financials, but on its governance culture, its CEO's decision-making style, and its litigation history. Luna: Most senior leaders I talk to spend more time vetting a $200,000 consulting contract than they do a board seat worth ten times that in equity. Lucas: That's the gap this episode is about. A board seat isn't just a credential — it's a fiduciary liability that can define the back half of a career. So today we're looking at the vetting framework that separates a career-enhancing board role from a reputational trap. Lucas: There are three phases. Phase one: governance audit. You need to understand the board's committee structure, meeting cadence, and whether the company has staggered or annual director elections. Those details tell you how much influence you'll actually have. Luna: And whether you're walking into a rubber-stamp culture. If the board hasn't replaced a director in twelve years, that's a flag. Lucas: Right. Phase two is liability mapping. You need to review the company's D&O insurance policy — specifically the coverage limits, the retention amount, and whether the policy covers securities claims and regulatory investigations. The industry standard for limits is around $10 million, but for a Fortune 500 company you want to see $20 million or more. Luna: And you have to check whether the company indemnifies directors for legal costs upfront, or only after a final judgment. That cash-flow difference matters if you're facing a multiyear lawsuit. Lucas: Phase three is cultural fit. This is the hardest to assess but the most important. You need to have off-the-record conversations with at least two former directors — people who left voluntarily. Ask them: when the CEO disagrees with the board, how does that conversation go? Do directors get briefing materials seven days in advance, or the night before? Luna: That's the kind of nuance you can't get from a proxy statement. And I'd add: ask about the board's relationship with the audit firm. If the external auditors have been in place for more than ten years, independence starts to erode. Lucas: Great point. So that's the framework. Now let's talk about negotiation — because senior leaders often leave money on the table when it comes to board terms. The equity grant is usually the largest component, but you can negotiate the vesting schedule. Most public company board grants vest over three years, but I've seen executives negotiate a one-year cliff for the initial grant. Luna: And term limits. Some boards have mandatory retirement at age 72, but you can ask for a shorter initial term — say, two years — to test the fit. If it's not working, you want an exit ramp that doesn't look like a firing. Lucas: Exactly. And let's talk about indemnification. The company's bylaws should include a clause that requires the company to advance legal fees for directors in any proceeding arising from their service. If that clause isn't there, or if it's limited to derivative suits only, that's a dealbreaker. Luna: I want to push back on something, though. There's a prestige bias — senior leaders are so flattered to be asked that they skip the hard questions. I've seen executives accept board seats at companies that are clearly struggling with regulatory issues, just because the brand name opens doors. Lucas: And that's how you end up like the former CEOs who served on the Wells Fargo board during the fake-accounts scandal. Their reputations took a decade-long hit. So here's the rule of thumb: if a board offer triggers more ego than caution, decline it. Luna: Honestly, if today's conversation helped you think about a board seat — or any career decision — there's a small way you can keep this show ad-free and independent. If it was worth a coffee to you, that's the link: buy me a coffee dot com slash fexingo. Lucas: And that really does make a difference. No pressure, just a sincere option for listeners who find value here. Luna: Back to the framework — one thing I want to add is the importance of understanding the board's risk appetite. Ask about the last time the board rejected a management proposal. If they can't remember, you're probably joining a board that defers too much. Lucas: That's a brilliant question. I'd also ask about the board's self-evaluation process. Does the board conduct peer reviews? Are individual director assessments shared with the full board? A transparent evaluation culture is a sign of a healthy board. Luna: And what about the CEO succession plan? If the board hasn't discussed it in the last year, that's a red flag. Even if the CEO is 45 and healthy, a board should always have a contingency plan. Lucas: Absolutely. So let me bring this back to the practical checklist. Before you sign anything, you should have: a copy of the D&O policy with limits and retentions, the company's bylaws with indemnification language, a list of current directors with their tenure and attendance records, and contact information for at least two former directors. Luna: And you should have a written commitment from the board chair that you'll be assigned to a substantive committee — not just the nominating and governance committee, which is often a dumping ground for new directors. Lucas: Right. Audit, compensation, or risk committee — those are where you can actually influence outcomes. Now, let's talk about what happens when you decide to decline. How do you do that without burning bridges? Luna: I think you frame it around fit rather than capability. Say: 'After doing my diligence, I don't think my expertise aligns with the board's current needs. I'd love to be considered again in a few years.' That leaves the door open. Lucas: And it signals that you took the process seriously. I've seen executives who declined a board seat get approached for a better one later, precisely because they handled the rejection professionally. Luna: There's also the question of portfolio construction. A senior leader should think of their board seats as a portfolio — no more than three public company boards at a time, and ideally a mix of industries and governance stages. Lucas: That's a good rule. If all three boards are in financial services, you're over-concentrated. If all three are mature companies with similar governance profiles, you're not learning anything new. Luna: So the ideal first board seat might be at a company that's smaller than the one you led, in a different sector, with a board that has a track record of director development. Lucas: Let me give you a concrete example. When Indra Nooyi joined the board of Amazon in 2019, she was already a former PepsiCo CEO. But Amazon was a completely different business model — e-commerce, cloud, logistics. She took that seat because it stretched her thinking. Luna: And she reportedly spent weeks meeting with Amazon's senior leaders across divisions before her first board meeting. That's the kind of preparation that turns a board seat into a career asset. Lucas: So to summarize: vet the governance, map the liability, assess the culture, negotiate the terms, and diversify your portfolio. One bad board seat can overshadow a decade of good executive work. Luna: And one good board seat can open doors you didn't know existed. The key is doing the work before you say yes. Lucas: That's it for this episode. Next time we'll look at how senior leaders handle the transition from executive to board chair — a shift that fewer than 20 percent navigate successfully. Until then, stay strategic.